Switch to:
More From Other Websites
ETF’s with exposure to Antares Pharma, Inc. : July 26, 2016 Jul 26 2016
ANTARES PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jul 01 2016
Antares Pharma (ATRS) in Focus: Stock Moves 10.2% Higher Jun 28 2016
TEVA and Antares Pharma Announce Launch of Generic Imitrex in the United States Jun 27 2016
Teva and Antares Pharma Announce Launch of Generic Imitrex® in the United States Jun 27 2016
Antares Pharma Announces Settlement of Patent Litigation for Key Alliance Business Product Jun 23 2016
Antares Pharma Announces Settlement of Patent Litigation for Key Alliance Business Product Jun 23 2016
ETF’s with exposure to Antares Pharma, Inc. : June 20, 2016 Jun 20 2016
ANTARES PHARMA, INC. Files SEC form 8-K, Other Events Jun 16 2016
ANTARES PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jun 08 2016
ANTARES PHARMA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 07 2016
ETF’s with exposure to Antares Pharma, Inc. : June 3, 2016 Jun 03 2016
Antares Pharma to Present at the Jefferies 2016 Healthcare Conference Jun 01 2016
Antares Pharma Announces Update to Quickshot Testosterone Program Jun 01 2016
Antares Pharma Announces Update to QuickShot Testosterone Clinical Program Jun 01 2016
ETF’s with exposure to Antares Pharma, Inc. : May 19, 2016 May 19 2016
Antares Pharma, Inc. :ATRS-US: Earnings Analysis: Q1, 2016 By the Numbers May 17 2016
ANTARES PHARMA, INC. Financials May 17 2016
ANTARES PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 09 2016
Antares Pharma Reports First Quarter 2016 Financial and Operating Results May 09 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK